This study investigates advanced solid tumors. The purpose of this study is to explore the safety of an investigational medication in people whose tumors have not responded to other treatments.
The study focuses on evaluating the safety and tolerability of the investigational medication. It looks at how the body processes the medication and its effects on participants.
- Who can participate: Adults 18 years and older with advanced solid tumors, who have not responded to standard treatments, can participate. Participants must have a good performance status.
- Study details: Participants will receive the investigational medication through an IV injection twice a week. An inactive substance called a placebo, which looks like the investigational medication but contains no medicine, may be used for comparison.
How understandable was the trial content above?
Hard to understand
Easy to understand